Email updates

Keep up to date with the latest news and content from Cell Regeneration and BioMed Central.

Journal App

google play app store
Open Access Research

The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes

Thomas Hill1, Olga Krougly1, Enayat Nikoopour1, Stacey Bellemore1, Edwin Lee-Chan1, Lynette A Fouser2, David J Hill34 and Bhagirath Singh156*

Author Affiliations

1 Department of Microbiology and Immunology, University of Western Ontario, London, ON, Canada

2 Inflammation and Immunology, Biotherapeutics Research and Development, Pfizer, Cambridge, MA, 02140, USA

3 Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada

4 Lawson Health Research Institute, London, ON, Canada

5 Centre for Human Immunology, University of Western Ontario, London, ON, Canada

6 Robarts Research Institute, University of Western Ontario, London, ON, Canada

For all author emails, please log on.

Cell Regeneration 2013, 2:2  doi:10.1186/2045-9769-2-2

Published: 4 April 2013



In Type 1 diabetes, the insulin-producing β-cells within the pancreatic islets of Langerhans are destroyed. We showed previously that immunotherapy with Bacillus Calmette-Guerin (BCG) or complete Freund’s adjuvant (CFA) of non-obese diabetic (NOD) mice can prevent disease process and pancreatic β-cell loss. This was associated with increased islet Regenerating (Reg) genes expression, and elevated IL-22-producing Th17 T-cells in the pancreas.


We hypothesized that IL-22 was responsible for the increased Reg gene expression in the pancreas. We therefore quantified the Reg1, Reg2, and Reg3δ (INGAP) mRNA expression in isolated pre-diabetic NOD islets treated with IL-22. We measured IL-22, and IL-22 receptor(R)-α mRNA expression in the pancreas and spleen of pre-diabetic and diabetic NOD mice. Our results showed: 1) Reg1 and Reg2 mRNA abundance to be significantly increased in IL-22-treated islets in vitro; 2) IL-22 mRNA expression in the pre-diabetic mouse pancreas increased with time following CFA treatment; 3) a reduced expression of IL-22Rα following CFA treatment; 4) a down-regulation in Reg1 and Reg2 mRNA expression in the pancreas of pre-diabetic mice injected with an IL-22 neutralizing antibody; and 5) an increased islet β-cell DNA synthesis in vitro in the presence of IL-22.


We conclude that IL-22 may contribute to the regeneration of β-cells by up-regulating Regenerating Reg1 and Reg2 genes in the islets.

Adjuvant immunotherapy; Interleukin-22; Regenerating (Reg) genes; Beta-cell regeneration; Type 1 diabetes